23andMe CEO, Anne Wojcicki 23andMe Sales of consumer-focused DNA tests from companies like Ancestry and 23andMe are down this year. And while companies in the space aren’t offering any reasons why, experts speculate that the natural expiration of the early adopter wave and growing privacy concerns are to blame. But companies might be able to… Read More »
The mammoth consumer health deal Pfizer and GlaxoSmithKline struck last December is finally sealed. But things are looking markedly different at Pfizer than they did seven months ago—and that may not be a good thing, analysts say. Earlier this week, the New York drugmaker agreed to merge its off-patent drugs business, dubbed Upjohn, with Mylan,… Read More »
Chicago, Los Angeles and Miami are the cities most likely to see the next measles outbreaks, according to an unusual new study. Researchers at the University of Texas at Austin and Johns Hopkins University mapped the 25 American counties most at risk of measles because of their vaccine-exemption rates and proximity to airports. A similar… Read More »
Fire prevention is a collaborative effort with local, state and federal agencies and private landowners — and it’s being held up because of the federal government shutdown. “With the federal government being out for 30-plus days, it makes good forest management and good wildfire preparation incredibly difficult,” Cottam said. “This is really troubling for anyone… Read More »
The Republican-led Congress was unable to repeal the Affordable Care Act in 2017, but the Trump administration continues to implement elements of the failed GOP bill using executive authority. The latest change would make it easier for states to waive some major parts of the health law, including allowing subsidies for people to buy insurance… Read More »